Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare
Lexicon Pharmaceuticals, Inc. Shareholder Equity 2009–2025
Lexicon Pharmaceuticals, Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lexicon Pharmaceuticals, Inc. shareholder equity as of December 31, 2025: 107.5M, a 26.32% decrease year-over-year.
- Lexicon Pharmaceuticals, Inc. shareholder equity for 2025 were 107.5M, a 26.32% decrease from 2024.
- Lexicon Pharmaceuticals, Inc. shareholder equity for 2024 were 145.9M, a 56.75% increase from 2023.
- Lexicon Pharmaceuticals, Inc. shareholder equity for 2023 were 93.1M, a 20.50% decrease from 2022.
- Lexicon Pharmaceuticals, Inc. shareholder equity for 2022 were 117.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lexicon Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $108 |
| 2024 | $146 |
| 2023 | $93 |
| 2022 | $117 |
| 2021 | $114 |
| 2020 | $156 |
| 2019 | $117 |
| 2018 | $-26 |
| 2017 | $68 |
| 2016 | $168 |
| 2015 | $286 |
| 2014 | $284 |
| 2013 | $170 |
| 2012 | $267 |
| 2011 | $298 |
Lexicon Pharmaceuticals, Inc. Shareholder Equity — FAQ
Lexicon Pharmaceuticals, Inc. (LXRX) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LXRX's shareholder equity history?
The chart and table above show Lexicon Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.